Skip to main menu Skip to footer
Retina Australia logo
Retina Australia logo
  • About Us
    • What we do
    • Our Team
    • Retina Australia celebrates 40 years
    • Membership
    • Supporters and Alliances
    • News
    • Reports
  • Research
    • Research into inherited retinal disease
    • Research impact reports
    • Strategy and governance
    • Apply for grant funding
  • Inherited retinal disease
    • About inherited retinal disease
    • Types of inherited retinal diseases
    • Other retinal dystrophies
    • Genetic testing
    • Clinical Trials
    • IRD Research Project and Clinical Trial Register
    • Emerging treatments
    • Frequently asked questions
  • Support
    • Blog
    • Newsletters
    • Webinars and Events
    • Guide for the newly diagnosed
    • Other guides for support
    • Community Billboard
    • Eye care professionals
    • Looking after your eyes
    • Vision loss aids
    • Become A Member
  • Help Us
    • Make A Donation
    • Do It In The Dark
    • Leave a gift in your Will
    • Get Active for Retina Australia
    • Host A Fundraiser
    • Become A Member
    • Volunteer With Us
DONATE
DONATE

Follow us

Visit our Youtube account Visit our Twitter account Visit our Facebook page Visit our Instagram account Visit our Linkedin page

Cell therapy, genetic research and a patient’s perspective

Hosted by Retina Australia   |   October 2024

Retina Australia was delighted to welcome Dr Anai Gonzalez-Cordero, from the Children’s Medical Research Institute, Sydney, Dr Ceecee Britten-Jones from the Centre for Eye Research, Melbourne, and Retina Australia Board Member Dino Farronato to present this webinar, held on Saturday 19th October.  You can view a recording of the webinar below.  

 

Photo of Anai Gonzalez-Cordero
Read more about Dr Anai-Gonzalez Cordero

The use of cell therapy in the development of a universal therapy for inherited retinal blindness

Presenter: Dr Anai Gonzalez-Cordero, Children’s Medical Research Institute, Sydney

Dr Gonzalez-Cordero will present an overview of her research on developing cell therapy to develop a universal therapy for inherited retinal blindness. She will explain how stem cell technology, including retinal organoids derived from pluripotent stem cells, serve as an ideal source of cells, specifically the light-sensing cells of the eye, the photoreceptors for transplantation. Efficacy for this approach has been establish during years of research and now her team is testing new methodologies to improve transplantation outcomes as well as translating the current approaches to good manufacturing practice (GMP) methods. Dr Gonzalez-Cordero will cover the pathway towards developing this advanced therapy.

Decoding the genetic puzzle of inherited retinal diseases through collaborative research

Presenter:  Dr Ceecee Britten-Jones, Centre for Eye Research, Melbourne

With advancing genetic technologies, having an accurate genetic diagnosis is increasingly important for managing inherited retinal diseases (IRDs) and accessing new gene therapy treatments. However, not everyone undergoing genetic testing can receive a confirmed diagnosis. Challenges remain in analysing and interpreting genetic data to provide answers for all individuals with IRDs. Working together to deepen this understanding is critical for improving individual care and has broader implications for advancing research and developing new therapies.

Dr Ceecee Britten-Jones leads genetic research studies at the Centre for Eye Research Australia and the University of Melbourne, working alongside the team on the Victorian Evolution of IRDs Natural History Registry (VENTURE). In this presentation, she will provide an overview of the new genetic research initiatives her team is leading and their impact on advancing IRD research and access to therapies. Ceecee will also talk about the current state of genetic research in IRDs, the processes required to achieve a diagnosis, and their team’s collaborative efforts to improve outcomes for individuals living with IRDs.

Photo of Ceecee Britten Jones
Read more about Dr Ceecee Britten

The VENTURE study - a participant's view

Presenter:  Dino Farronato, Retina Australia Board Member

Dino faces the challenges of dealing with an inherited retinal disease on a daily basis. He was diagnosed with retinitis pigmentosa in his early 30s and is constantly adapting to consequential changes to his vision. He is committed to supporting others affected by inherited retinal diseases, as well as raising the funds required to provide grants for innovative research into such diseases.

Dino will briefly discuss his involvement in the VENTURE clinical and genetic study conducted by CERA. He will cover his motivation for joining the study; his experience as a participant and the follow-up once the genetic testing was completed.

Dino joined the Board of Retina Australia in October 2023.  Dino is a lawyer with over 35 years’ experience working with professional service firms and a large, multinational conglomerate. He has lived and worked in Asia for many years, and he has been a partner at PWC and since 2012, the proprietor of an independent business advisory practice, catering to international and national clients. 
 
Dino faces the challenges of dealing with an inherited retinal disease on a daily basis. He was diagnosed with Retinitis Pigmentosa in his early 30s and is constantly adapting to consequential changes to his vision. He is committed to supporting others affected by inherited retinal diseases, as well as raising the funds required to provide grants for innovative research into such diseases. 
 

 

Read more about Dino Farronato
Share this webinar
  • Share 'Cell therapy, genetic research and a patient’s perspective' via Twitter
  • Share 'Cell therapy, genetic research and a patient’s perspective' via Facebook
  • Share 'Cell therapy, genetic research and a patient’s perspective' via LinkedIn
  • Share 'Cell therapy, genetic research and a patient’s perspective' via Email
  • Copy link to 'Cell therapy, genetic research and a patient’s perspective'
https://retinaaustralia.com.au/webinars/the-use-of-cell-therapy-in-the-development-of-a-universal-therapy-for-inherited-retinal-blindness/

Past Webinars

May 2024

Research Update Event – Geographic atrophy and AMD

   

Read More about Research Update Event – Geographic atrophy and AMD

October 2023

Vision Loss Priority Setting Partnership and an Introduction to Stem Cell & Gene Therapies

   

Read More about Vision Loss Priority Setting Partnership and an Introduction to Stem Cell & Gene Therapies

August 2023

RNA-based gene editing and testing of a gene-independent treatment strategy

Read More about RNA-based gene editing and testing of a gene-independent treatment strategy
VIEW ALL about Past webinars
RA Australia logo Retina Australia is an ACNC registered charity - Visit ACNC
Follow us:
Visit our Youtube account Visit our Twitter account Visit our Facebook page Visit our Instagram account Visit our Linkedin page
  • 1800 999 870
  • info@retinaaustralia.com.au
  • Level 3 Ross House 247-251 Flinders Lane
    Melbourne VICTORIA 3000
  • About Us
  • Research
  • Inherited retinal disease
  • Contact Us
  • Support
  • Help Us
  • Donate
  • Subscribe

Retina Australia acknowledges the Traditional custodians of the land and pay our respects to Elders past, present and emerging.

© 2025 Retina Australia ABN 26 059 846 829

  • Privacy
  • Cookies
  • Security
  • Accessibility
  • Disclaimer
This website was verified to the level of AA conformance against WCAG 2.1 achieved on 17/9/2021
RA Australia logo
Retina Australia is an ACNC registered charity - Visit ACNC
  • 1800 999 870
  • info@retinaaustralia.com.au
  • Level 3 Ross House 247-251 Flinders Lane
    Melbourne VICTORIA 3000
  • About Us
  • Research
  • Inherited retinal disease
  • Contact Us
  • Support
  • Help Us
  • Donate
  • Subscribe
Follow us:
Visit our Youtube account Visit our Twitter account Visit our Facebook page Visit our Instagram account Visit our Linkedin page

© 2025 Retina Australia ABN 26 059 846 829

  • Privacy
  • Cookies
  • Security
  • Accessibility
  • Disclaimer
Subscribe to Retina Insider

Subscribe to our free monthly newsletter to keep up with the latest news related to inherited retinal diseases, including research updates and clinical trials.